Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health Inc experienced substantial growth, with last twelve months (LTM) calculated billings increasing nearly 44% year-over-year to $671 million and client count rising by 25% year-over-year, indicating strong demand for its services. The company also reported a revenue increase of 46% year-over-year to $170.7 million, outpacing consensus estimates and reflecting effective market penetration and customer engagement. Additionally, guidance for future revenue suggests continued positive momentum, forecasting a 25% year-over-year increase in projected annual revenue, further supported by expectations of market share gains and growing utilization rates.

Bears say

Hinge Health Inc. faces a negative outlook due to expectations of a macro-driven weak spending environment impacting growth in FY26. Despite providing guidance for non-GAAP operating income and margins that surpass consensus estimates, the company's reliance on employee utilization to drive billings growth introduces additional risk, warranting a lower EV/revenue multiple compared to peers. Furthermore, competition is intensifying not from direct rivals but from budgetary constraints leading potential clients to delay decisions, which could adversely affect Hinge's future revenue potential.

HNGE has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 17 analysts, HNGE has a Buy consensus rating as of Mar 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $58.94, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $58.94, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.